Literature DB >> 21394119

Treating peripapillary choroidal neovascular membranes: a review of the evidence.

G Jutley1, G Jutley1, V Tah, D Lindfield, G Menon.   

Abstract

Peripapillary choroidal neovascular membranes (PCNM) are defined as a collection of new choroidal blood vessels, any portion of which lies within one disc diameter of the nerve head. There are two types of PCNM, and correct pre-interventional identification of growth site has been shown to stratify the chance of visual improvement following therapy. Clinical manifestations occur only where the membrane extends over the macula, if the vessels haemorrhage into the subretinal space or fluid exudation occurs within the macula. This review provides an update and overview on the diverse range of current treatment studies and strategies being used in present clinical ophthalmic practice.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21394119      PMCID: PMC3178139          DOI: 10.1038/eye.2011.24

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  27 in total

Review 1.  Peripapillary subretinal neovascularization. A review.

Authors:  P F Lopez; W R Green
Journal:  Retina       Date:  1992       Impact factor: 4.256

2.  Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia.

Authors:  Q D Nguyen; S Shah; S Tatlipinar; D V Do; E V Anden; P A Campochiaro
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

3.  Histopathologic and ultrastructural features of surgically excised subfoveal choroidal neovascular lesions: submacular surgery trials report no. 7.

Authors:  Hans E Grossniklaus; Päivi H Miskala; W Richard Green; Susan B Bressler; Barbara S Hawkins; Cynthia Toth; David J Wilson; Neil M Bressler
Journal:  Arch Ophthalmol       Date:  2005-07

4.  Combination photodynamic therapy and juxtascleral triamcinolone acetonide for the treatment of a peripapillary choroidal neovascular membrane associated with papilloedema.

Authors:  A Tewari; G K Shah; M S Dhalla; J B Shepherd
Journal:  Br J Ophthalmol       Date:  2006-10       Impact factor: 4.638

5.  Evolving peripapillary choroidal neovascular membrane demonstrated by indocyanine green choroidal angiography.

Authors:  S Wolf; K J Wald; A Remky; O Arend; M Reim
Journal:  Retina       Date:  1994       Impact factor: 4.256

6.  Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes.

Authors:  J D Gass
Journal:  Am J Ophthalmol       Date:  1994-09-15       Impact factor: 5.258

7.  The visual outcome of peripapillary choroidal neovascular membranes.

Authors:  S Ruben; H Palmer; R J Marsh
Journal:  Acta Ophthalmol (Copenh)       Date:  1994-02

8.  Photodynamic therapy with verteporfin for peripapillary choroidal neovascularization.

Authors:  Brett J Rosenblatt; Gaurav K Shah; Kevin Blinder
Journal:  Retina       Date:  2005-01       Impact factor: 4.256

9.  Ranibizumab for neovascular age-related macular degeneration.

Authors:  Philip J Rosenfeld; David M Brown; Jeffrey S Heier; David S Boyer; Peter K Kaiser; Carol Y Chung; Robert Y Kim
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

10.  Surgical removal of peripapillary choroidal neovascularization associated with age-related macular degeneration.

Authors:  Kevin J Blinder; Gaurav K Shah; Matthew A Thomas; Nancy M Holekamp; Daniel P Joseph; M Gilbert Grand; Sanjay Sharma
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2005 Sep-Oct
View more
  7 in total

1.  Pseudotumor cerebri syndrome causing a terson like syndrome.

Authors:  Joseph Raevis; Valerie I Elmalem
Journal:  Am J Ophthalmol Case Rep       Date:  2020-11-24

Review 2.  Photodynamic therapy: current role in the treatment of chorioretinal conditions.

Authors:  D K Newman
Journal:  Eye (Lond)       Date:  2016-01-08       Impact factor: 3.775

3.  An efficacy analysis of anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to multifocal choroiditis and comparison with wet age-related macular degeneration.

Authors:  Lei Feng; Jiang-Hua Hu; Jie Chen; Xin Xie
Journal:  J Zhejiang Univ Sci B       Date:  2018 Apr.       Impact factor: 3.066

4.  Effect of intravitreal ranibizumab in the treatment of peripapillary choroidal neovascularisation.

Authors:  Hassan Hamoudi; Torben Lykke Sørensen
Journal:  J Ophthalmol       Date:  2011-12-22       Impact factor: 1.909

5.  Idiopathic Peripapillary Subretinal Neovascular Membrane in a Young Woman with Recurrence of the Lesion during Pregnancy after Treatment with Intravitreal Bevacizumab.

Authors:  Nasra Al-Gharbi; Omar Al Abdulsalam; Ahmed Al Habash
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Apr-Jun

6.  Peripapillary Choroidal Neovascularization Associated with Optic Nerve Head Drusen Treated with Anti-VEGF Agents.

Authors:  Norman A Saffra; Benjamin J Reinherz
Journal:  Case Rep Ophthalmol       Date:  2015-02-10

7.  Choroidal Neovascularization in Pediatric Patients: Analysis of Etiologic Factors, Clinical Characteristics and Treatment Outcomes.

Authors:  Ting Zhang; You Wang; Wenjia Yan; Yafen Liu; Jinglin Lu; Limei Sun; Songshan Li; Li Huang; Zhaotian Zhang; Xiaoyan Ding
Journal:  Front Med (Lausanne)       Date:  2021-11-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.